Screener
Sarepta Therapeutics, Inc. SRPT Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total other comprehensive (loss) income | (444) | (85) | (837) | 167 |
| Comprehensive (loss) income | $(5,334) | $196,807 | $325,232 | $(250,449) |
| (Loss) earnings per share: | ||||
| Basic | $(0.05) | $2.01 | $3.10 | $(2.57) |
| Diluted | $(0.05) | $1.89 | $2.99 | $(2.57) |
| Weighted average number of shares of common stock used in computing (loss) earnings per share: | ||||
| Basic | 105,431 | 98,005 | 105,211 | 97,685 |
| Diluted | 105,431 | 106,623 | 122,260 | 97,685 |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s shares (diluted)?
- Sarepta Therapeutics, Inc. (SRPT) reported shares (diluted) of 105.4M in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s shares (diluted) changed year-over-year?
- Sarepta Therapeutics, Inc.'s shares (diluted) decreased by 1.1% year-over-year, from 106.6M to 105.4M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Sarepta Therapeutics, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude